Variant report
Variant | esv3388174 |
---|---|
Chromosome Location | chr7:14348761-14369819 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:14363416..14366270-chr7:14373533..14375322,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112054886 | chr7:14352623-14352624 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571476614 | chr7:14352640-14352641 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530684789 | chr7:14352705-14352706 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141327271 | chr7:14352709-14352710 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566953791 | chr7:14352718-14352719 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184222565 | chr7:14352731-14352732 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143839381 | chr7:14352739-14352740 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35689654 | chr7:14352767-14352768 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs566521321 | chr7:14352827-14352828 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534908800 | chr7:14352880-14352881 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558302722 | chr7:14352882-14352883 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201515519 | chr7:14352883-14352884 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537774678 | chr7:14352884-14352885 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6461083 | chr7:14352885-14352886 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs190769577 | chr7:14352894-14352895 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543031666 | chr7:14352906-14352907 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559598889 | chr7:14352914-14352915 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146878186 | chr7:14352921-14352922 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140733792 | chr7:14352922-14352923 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565125356 | chr7:14352939-14352940 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533304708 | chr7:14352944-14352945 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6461084 | chr7:14352945-14352946 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs529650929 | chr7:14352947-14352948 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546528935 | chr7:14352948-14352949 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566466304 | chr7:14352956-14352957 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538692251 | chr7:14352957-14352958 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373302411 | chr7:14352958-14352959 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377325484 | chr7:14352960-14352961 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6461085 | chr7:14352971-14352972 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571897625 | chr7:14352988-14352989 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557705347 | chr7:14358431-14358432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571022852 | chr7:14358444-14358445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536782507 | chr7:14358456-14358457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188368515 | chr7:14358462-14358463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576272361 | chr7:14358463-14358464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530285088 | chr7:14358475-14358476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555790852 | chr7:14358476-14358477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111787746 | chr7:14358487-14358488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192653589 | chr7:14358500-14358501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564507653 | chr7:14358503-14358504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536938085 | chr7:14358521-14358522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543981473 | chr7:14358554-14358555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372139540 | chr7:14358562-14358563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184641397 | chr7:14358575-14358576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529085840 | chr7:14358587-14358588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369277954 | chr7:14358595-14358596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549114856 | chr7:14358627-14358628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4404823 | chr7:14358653-14358654 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs528351420 | chr7:14358655-14358656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551244118 | chr7:14358702-14358703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Colorectal cancer | 21645411 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:14352600-14353000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
2 | chr7:14352600-14353000 | Active TSS | HUES48 Cell Line | embryonic stem cell |
3 | chr7:14352600-14353000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
4 | chr7:14358400-14361800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
5 | chr7:14361800-14362000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr7:14366400-14366600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr7:14366600-14367400 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr7:14366800-14371800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr7:14368000-14368800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr7:14368200-14368800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr7:14368200-14369000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr7:14368200-14369000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr7:14368400-14368800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr7:14368400-14369000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr7:14368800-14371800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr7:14368800-14375600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr7:14368800-14379000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |